Search

Clay D Fette

age ~48

from Davie, FL

Also known as:
  • Clay David Fette
  • Clay Danielle Fette
  • Clay Amber Fette
  • David L Fette
  • David Fette Clay

Clay Fette Phones & Addresses

  • Davie, FL
  • Orlando, FL
  • Severna Park, MD
  • Crete, NE
  • 1503 Austin Dr, Lebanon, IN 46052
  • Indianapolis, IN
  • Palm Beach Gardens, FL
  • Jupiter, FL

Us Patents

  • Stent Tissue Graft Prosthesis

    view source
  • US Patent:
    7914567, Mar 29, 2011
  • Filed:
    Nov 21, 2003
  • Appl. No.:
    10/719415
  • Inventors:
    Dusan Pavcnik - Portland OR, US
    Clay D. Fette - Lebanon IN, US
    Jason A. Mead - Plainfield IN, US
    Joseph F. Obermiller - West Lafayette IN, US
    Fred T. Parker - Unionville IN, US
  • Assignee:
    Oregon Health & Science University - Portland OR
    Cook Incorporated - Bloomington IN
    Cook Biotech, Inc. - West Lafayaette IN
  • International Classification:
    A61F 2/06
  • US Classification:
    623 113, 623 116
  • Abstract:
    A stent tissue graft prosthesis () for repairing, excluding and/or reinforcing a vessel, duct and the like in a patient. The prosthesis includes an inner expandable stent () of which a tissue graft () and preferably a multilayered tissue construct () is disposed thereon for application to the host tissue of a vessel, duct and the like. The tissue construct includes an extracellular matrix material () such as small intestine submucosa () for remodeling the host tissue into the prosthesis. The prosthesis further includes an outer tubular member () such as an outer expandable stent () for retaining the tissue graft on the inner stent. The ends of the inner and outer stents are coincident with or extend beyond the ends of the tissue graft to prevent eversion or fold back of the tissue graft during withdrawal of a delivery catheter in a placement procedure.
  • Bodily Lumen Closure Apparatus And Method

    view source
  • US Patent:
    8317823, Nov 27, 2012
  • Filed:
    Apr 25, 2008
  • Appl. No.:
    12/109574
  • Inventors:
    Dusan Pavcnik - Portland OR, US
    John Kaufman - Lake Oswego OR, US
    Clay D. Fette - Lebanon IN, US
  • Assignee:
    Cook Biotech Incorporated - West Lafayette IN
    Oregon Health Science University - Portland OR
  • International Classification:
    A61B 17/08
  • US Classification:
    606213, 623 2372
  • Abstract:
    An absorbable and expandable closure member used to occlude or exclude a body lumen or cavity, such as a blood vessel, fallopian tube, duct, aneurysmal sac, etc. , comprising a closure member comprising one of more sheets of a biomaterial that are rolled, stacked, or folded to form a multilayer construct of a generally cylindrical configuration for deployment through a delivery system, either as a singularly or part of a multiplicity of closure members. The biomaterial is derived from a source material, such as small intestinal submucosa or another remodelable material (e. g. , an extracellular matrix) having properties for stimulating ingrowth of adjacent tissue into the biomaterial deployed within the bodily lumen. The closure member is deployed to the bodily lumen from a delivery sheath, cartridge, and/or over a inner guiding member, such as a wire guide or catheter.
  • Bodily Lumen Closure Apparatus And Method

    view source
  • US Patent:
    8465516, Jun 18, 2013
  • Filed:
    May 12, 2004
  • Appl. No.:
    10/843990
  • Inventors:
    Dusan Pavcnik - Portland OR, US
    John Kaufman - Lake Oswego OR, US
    Clay D. Fette - Lebanon IN, US
  • Assignee:
    Oregon Health Science University - Portland OR
    Cook Biotech Incorporated - West Lafayette IN
    Cook Medical Technologies LLC - Bloomington IN
  • International Classification:
    A61B 17/08
  • US Classification:
    606213, 623 2372
  • Abstract:
    An absorbable and expandable closure member used to occlude or exclude a body lumen or cavity, such as a blood vessel, fallopian tube, duct, aneurysmal sac, etc. , comprising a closure member comprising one of more sheets of a biomaterial that are rolled, stacked, or folded to form a multilayer construct of a generally cylindrical configuration for deployment through a delivery system, either as a singularly or part of a multiplicity of closure members. The biomaterial is derived from a source material, such as small intestinal submucosa or another remodelable material (e. g. , an extracellular matrix) having properties for stimulating ingrowth of adjacent tissue into the biomaterial deployed within the bodily lumen. The closure member is deployed to the bodily lumen from a delivery sheath, cartridge, and/or over a inner guiding member, such as a wire guide or catheter.
  • Tissue Graft Composition

    view source
  • US Patent:
    8541032, Sep 24, 2013
  • Filed:
    Oct 11, 2012
  • Appl. No.:
    13/649522
  • Inventors:
    Miles Grody - Columbia MD, US
    Clay Fette - Severna Park MD, US
  • Assignee:
    ACell, Inc. - Columbia MD
  • International Classification:
    A61K 35/12
    A61K 35/32
  • US Classification:
    424572, 424574, 424443, 424444
  • Abstract:
    Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.
  • Anastomosis Device For Vascular Access

    view source
  • US Patent:
    20050038455, Feb 17, 2005
  • Filed:
    May 12, 2004
  • Appl. No.:
    10/843816
  • Inventors:
    Brian Bates - Bloomington IN, US
    Clay Fette - Lebanon IN, US
    Ram Paul - Bloomington IN, US
    Paul Amarant - Bloomington IN, US
  • Assignee:
    COOK INCORPORATED - Bloomington IN
    COOK BIOTECH INCORPORATED - West Lafayette IN
  • International Classification:
    A61F002/06
    A61B017/08
  • US Classification:
    606153000, 606151000, 623001150
  • Abstract:
    An anastomosis device () for advantageously bridging an artery and a vein. The anastomosis device includes a tubular graft () with first and second ends (and ) and a longitudinal passageway extending longitudinally through the graft. The device further includes a first stent () disposed about the first end of the tubular graft and a second stent () disposed about the second end of the tubular graft. Each of the first and second stents has a plurality of hooks or barbs () pointed or releasable to the point toward the other end of the graft.
  • Optical Safety Trocar And Method Of Use Thereof

    view source
  • US Patent:
    20090270819, Oct 29, 2009
  • Filed:
    Apr 29, 2008
  • Appl. No.:
    12/111625
  • Inventors:
    Dario Vitali - New Smyma Beach FL, US
    Rogelio Insignares - Miami FL, US
    Ken Roger - Casselbury FL, US
    Clay Fette - Palm Beach Gardens FL, US
  • International Classification:
    A61M 5/158
  • US Classification:
    604272
  • Abstract:
    An optical safety trocar and method of use thereof, wherein a shield deploys to guard against accidental tip contact and potential injury therefrom, and wherein an optical tip facilitates visualization of the trocar advancement into a body cavity, such that the visualization not only precludes blind penetration in order to avoid inadvertently injurious positioning of the tip, but enables identification of any unintentional and otherwise undetectable damage.
  • Hemostatic Device

    view source
  • US Patent:
    20130150883, Jun 13, 2013
  • Filed:
    Dec 6, 2012
  • Appl. No.:
    13/706987
  • Inventors:
    Clay Fette - Severna Park MD, US
    Abram Janis - Columbia MD, US
    Benjamin Kibalo - Columbia MD, US
  • International Classification:
    A61B 17/00
  • US Classification:
    606213, 424484, 424 937
  • Abstract:
    A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.
  • Compositions With Antiviral Activity And Related Methods

    view source
  • US Patent:
    20210330711, Oct 28, 2021
  • Filed:
    Apr 22, 2021
  • Appl. No.:
    17/237239
  • Inventors:
    - Davie FL, US
    Clay FETTE - Davie FL, US
  • Assignee:
    FETTECH, LLC - Davie FL
  • International Classification:
    A61K 35/26
    A61K 35/42
  • Abstract:
    Compositions that include extracellular matrix (ECM) materials having antiviral activity and methods of use thereof are disclosed. The compositions may be administered to a subject in need thereof, e.g., subject having a viral infection or being suspected of having a viral infection. The virus may be an enveloped virus, such as a coronavirus.
Name / Title
Company / Classification
Phones & Addresses
Clay Fette
Vice-President
Credit Management Solutions, Inc
Custom Computer Programing
6640 Eli Whitney Dr, Columbia, MD 21046
8671 Robert Fulton Dr, Columbia, MD 21046
(410)9536464

Youtube

Fettes neues WB-Clay! | Lockhart's Ftte Clay ...

+++ FOR ENGLISH PLEASE ACTIVATE SUBTITLES +++ In unserem heutigen Revi...

  • Duration:
    8m 27s

Lockharts FATTE CLAY Review | WB that works l...

Happy 4th! Today we're having a look at the latest addition to the Loc...

  • Duration:
    9m 14s

Lockhart's Ftte Clay Full Demo & Review & Com...

Check out The Lockhart's Shop!- USE CODE MODERNMANTV TO SAVE SOME...

  • Duration:
    8m 59s

Ftte Clay vs Lockharts vs den Rest

I am NOT associated, affiliated OR supported by any brand or company t...

  • Duration:
    12m 44s

Tutorial per creare fette di ananas (clays pi...

come creare fette di ananas in pasta da modellare in poche semplici mo...

  • Duration:
    4m 25s

Smurfette's Death

All footage belongs to the respective studios. I do not own anything.

  • Duration:
    3m 46s

Flickr


Get Report for Clay D Fette from Davie, FL, age ~48
Control profile